TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q2 2023 Earnings Call Transcript August 14, 2023
TRACON Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.22 EPS, expectations were $0.36.
Operator: Good day, ladies and gentlemen, and welcome to the TRACON Pharmaceuticals’ Second Quarter 2023 Earnings Conference Call. At this time, all callers are in a listen-only mode. After the speakers’ prepared remarks, we’ll conduct a question-and-answer session and instructions...
